14-77555499-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_004863.4(SPTLC2):c.977G>A(p.Arg326His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,614,082 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004863.4 missense
Scores
Clinical Significance
Conservation
Publications
- neuropathy, hereditary sensory and autonomic, type 1CInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics
- hereditary sensory and autonomic neuropathy type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SPTLC2 | NM_004863.4 | c.977G>A | p.Arg326His | missense_variant | Exon 8 of 12 | ENST00000216484.7 | NP_004854.1 | |
| SPTLC2 | XM_011537384.3 | c.977G>A | p.Arg326His | missense_variant | Exon 8 of 10 | XP_011535686.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152082Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000278 AC: 7AN: 251398 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.000114 AC: 166AN: 1461882Hom.: 0 Cov.: 32 AF XY: 0.000105 AC XY: 76AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74402 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Neuropathy, hereditary sensory and autonomic, type 1C Uncertain:2
The SPTLC2 c.977G>A; p.Arg326His variant (rs116822112), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 579155). This variant is found in the non-Finnish European population with an allele frequency of 0.0053% (6/113,698 alleles) in the Genome Aggregation Database. The arginine at codon 326 is moderately conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.565). Due to limited information, the clinical significance of this variant is uncertain at this time. -
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 326 of the SPTLC2 protein (p.Arg326His). This variant is present in population databases (rs116822112, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with SPTLC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 579155). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.977G>A (p.R326H) alteration is located in exon 8 (coding exon 8) of the SPTLC2 gene. This alteration results from a G to A substitution at nucleotide position 977, causing the arginine (R) at amino acid position 326 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at